Quality-of-Life Outcomes Underreported in GU Cancer Trials

(MedPage Today) — SAN FRANCISCO — Despite a growing emphasis on quality-of-life (QoL) endpoints and patient-reported outcomes in cancer trials, the reporting of those results has been inconsistent for prostate, kidney, and bladder cancer trials…